BabyO2 is a Topical Solution in the Human Otc Drug category. It is labeled and distributed by Oxigenesis, Inc.. The primary component is Silver; Glycerin.
Product ID | 72136-005_9985b88d-2b8a-4b22-8282-3d69302aef84 |
NDC | 72136-005 |
Product Type | Human Otc Drug |
Proprietary Name | BabyO2 |
Generic Name | Colloidal Silver And Glycerin |
Dosage Form | Solution |
Route of Administration | TOPICAL |
Marketing Start Date | 2019-02-26 |
Marketing Category | UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER |
Labeler Name | Oxigenesis, Inc. |
Substance Name | SILVER; GLYCERIN |
Active Ingredient Strength | 2 mg/240mL; mg/240mL |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2019-02-26 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | unapproved drug other |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2019-02-26 |
Ingredient | Strength |
---|---|
SILVER | 2 mg/240mL |
SPL SET ID: | 9ee0b8da-4f82-46e9-88ae-0f7710fd8d53 |
Manufacturer | |
UNII | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
72136-005 | BabyO2 | Colloidal Silver and Glycerin |
72136-007 | BabyO2 | Silver, Zinc |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
BABYO2 90279222 not registered Live/Pending |
OXIGENESIS INC 2020-10-26 |